Results of the SMARTE-R-CHOP-14 trial of the German high-grade Non-Hodgkin Lymphoma study group (DSHNHL)

被引：0
|
作者：
Pfreundschuh, M. [1 ]
Poeschel, V [1 ]
Zeynalova, S. [2 ]
Viardot, A. [3 ]
Haenel, M. [4 ]
Keller, U. [5 ]
Reiser, M.
Murawski, N. [1 ]
Loeffler, M. [2 ]
Schubert, J. [6 ]
机构：
[1] Univ Klinikum Homburg, Homburg, Germany
[2] IMISE, Leipzig, Germany
[3] Univ Ulm Klinikum, Ulm, Germany
[4] Krankenhaus Kuchwald, Chemnitz, Germany
[5] Tech Univ Munich, Munich, Germany
[6] Ev Krankenhaus, Hamm, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [1] Results of SMARTE-R-CHOP-14 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL)
    Pfreundschuh, M.
    Poeschel, V.
    Zeynalova, S.
    Viardot, A.
    Haenel, M.
    Keller, U.
    Reiser, M.
    Murawski, N.
    Loeffler, M.
    Schubert, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Improved Outcome of Elderly Poor-Prognosis DLBCL Patients with 6xCHOP-14 and 8 Applications of Rituximab (R) Given Over An Extended Period: Results of the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
    Pfreundschuh, Michael
    Held, Gerhard
    Zeynalova, Samira
    Poeschel, Viola
    Viardot, Andreas
    Haenel, Matthias
    Keller, Ulrich
    Reiser, Marcel
    Loeffler, Markus
    Murawski, Niels
    [J]. BLOOD, 2011, 118 (21) : 272 - 273
  • [3] Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
    Pfreundschuh, Michael
    Poeschel, Viola
    Zeynalova, Samira
    Haenel, Mathias
    Held, Gerhard
    Schmitz, Norbert
    Viardot, Andreas
    Dreyling, Martin H.
    Hallek, Michael
    Mueller, Carsten
    Wiesen, Martin H. J.
    Witzens-Harig, Mathias
    Truemper, Lorenz
    Keller, Ulrich
    Rixecker, Tanja
    Zwick, Carsten
    Murawski, Niels
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4127 - U354
  • [4] Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (vol 32, pg 4127, 2014)
    Pfreundschuh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1991 - 1991
  • [5] 7-YEAR FOLLOW-UP OF THE RICOVER-60 TRIAL OF THE GERMAN HIGH-GRADE NON-HODGKIN LYMPHOMA STUDY GROUP (DSHNHL)
    Pfreundschuh, M.
    Ziepert, M.
    Zeynalova, S.
    Lengfelder, E.
    Steinhauer, H.
    Clemens, M.
    Nickenig, C.
    Ho, A. D.
    Truemper, L.
    Hoffmann, M.
    Mertelsmann, R.
    Metzner, B.
    Mergenthaler, H.
    Poeschel, V.
    Schmitz, N.
    Loeffler, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 193 - 193
  • [6] 7-year follow-up of the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
    Zwick, C.
    Ziepert, M.
    Zeynalova, S.
    Lengfelder, E.
    Steinhauer, H.
    Clemens, M.
    Nickenig, C.
    Ho, A. D.
    Truemper, L.
    Hoffmann, M.
    Mertelsmann, R.
    Metzner, B.
    Mergenthaler, H. -G.
    Poeschel, V.
    Schmitz, N.
    Loeffler, M.
    Pfreundschuh, M.
    [J]. ONKOLOGIE, 2011, 34 : 191 - 191
  • [7] Practicability and acute haematological toxicity of 2-and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
    Wunderlich, A
    Kloess, M
    Reiser, M
    Rudolph, C
    Truemper, L
    Bittner, S
    Schmalenberg, H
    Schmits, R
    Pfreundschuh, M
    Loeffler, M
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (06) : 881 - 893
  • [8] Dose-dense rituximab improves outcome of elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL)
    Pfreundschuh, Michael
    Zeynalova, Samira
    Poeschel, Viola
    Haenel, Mathias
    Schmitz, Norbert
    Hensel, Manfred
    Reiser, Marcel
    Loeffler, Markus
    Schubert, Joerg
    [J]. BLOOD, 2007, 110 (11) : 243A - 243A
  • [9] Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma:: II.: Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
    Pfreundschuh, M.
    Zwick, C.
    Zeynalova, S.
    Duehrsen, U.
    Ger, K. -H. Pflu
    Vrieling, T.
    Mesters, R.
    Mergenthaler, H. -G.
    Einsele, H.
    Bentz, M.
    Lengfelder, E.
    Truemper, L.
    Ruebe, C.
    Schmitz, N.
    Loeffler, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (03) : 545 - 552
  • [10] Dose-dense rituximab improves outcome of elderly patients with poor-prognosis Diffuse Large B-cell Lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 trial of the german high-grade non-hodgkin lymphoma study group (DSHNHL)
    Pfreundschuh, M.
    Zeynalova, S.
    Poeschel, V.
    Haenel, M.
    Schmitz, N.
    Hensel, M.
    Reiser, M.
    Loeffler, M.
    Schubert, J.
    [J]. ONKOLOGIE, 2008, 31 : 118 - +
12345